According to South Korean media reports on March 16, KT&G Company has decided to further enhance shareholder value by launching a 28 trillion Korean won shareholder return policy and deciding to destroy 3.5 million of its own shares. This 3.25 trillion won destruction is equivalent to 2.6% of the total issued shares. According to the Korea Exchange, KT&G's destruction accounts for 10% of the total amount of self-owned shares destroyed by listed companies that month.
According to reports, the board of directors of KT&G has decided to pay a dividend of 4,000 Korean won in 2023. This includes a final half-year dividend of 1,200 Korean won, bringing the total annual dividend to 5,200 Korean won per share, an increase of 200 Korean won from last year. The dividend yield is 5.7%. KT&G held a "Value Day" in November 2023, announcing a new shareholder return policy totaling 28 trillion Korean won to be implemented by 2026 to enhance shareholder value. In 2023, KT&G achieved a record high comprehensive sales revenue of 58.724 trillion Korean won.
Particularly, the overseas cigarette division achieved an annual sales revenue of 11.394 trillion Korean won, breaking a historical record. The combined annual sales revenue of overseas cigarettes, NGP (e-cigarettes), and health foods reached 33.127 trillion Korean won, a 1.1% increase from the previous year. KT&G's goal for this year is to increase comprehensive sales revenue by over 10% and operating profit by over 6%. Sales revenue and operating profit from the three core businesses are expected to increase by over 15% and 31.5% respectively compared to last year.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
